Brokerages Set Kymera Therapeutics, Inc. (NASDAQ:KYMR) Target Price at $131.62
Shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR – Get Free Report) have earned an average recommendation of “Moderate Buy” from the twenty-five ratings firms that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation, twenty-one have given a buy […]
22 Sep 09:28 · The Markets Daily